Autopsy report · NCT03233828

Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2

“Low enrollment numbers.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 3 months before it started.
• Ran for about 1 month before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 4 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Carman Giacomantonio

Sponsor type

University, hospital or other

Conditions

Melanoma (Skin); Melanoma in Situ

Interventions

Aldesleukin; Saline

Participants

1

Sites

1

Countries

Canada

Trials that died the same way

• A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation
  “Low enrollment rate.” (90% match in meaning)
• The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
  “Low enrollment.” (90% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.